# Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects

Study · id `cardio:ct-nct01994109` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01994109](<https://clinicaltrials.gov/study/NCT01994109>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01994109

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 187 participants.

## Technical summary

Registry record NCT01994109. Randomized; quadruple masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2016-01 (actual). Results posted on 2019-08-15.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 187 participants (enrolled count; ClinicalTrials.gov record NCT01994109, source copy `cardio:ctgov-nct01994109-2026-04-21`, retrieved 2026-10-26)
- Start date: 2013-11 (registry gives no type) (ClinicalTrials.gov record NCT01994109, source copy `cardio:ctgov-nct01994109-2026-04-21`, retrieved 2026-10-26)
- Primary completion: 2016-01 (actual) (ClinicalTrials.gov record NCT01994109, source copy `cardio:ctgov-nct01994109-2026-04-21`, retrieved 2026-10-26)
- Completion: 2017-01 (actual) (ClinicalTrials.gov record NCT01994109, source copy `cardio:ctgov-nct01994109-2026-04-21`, retrieved 2026-10-26)
- Results first posted: 2019-08-15 (ClinicalTrials.gov record NCT01994109, source copy `cardio:ctgov-nct01994109-2026-04-21`, retrieved 2026-10-26)
- Countries: United States; Russia; Ukraine (ClinicalTrials.gov record NCT01994109, source copy `cardio:ctgov-nct01994109-2026-04-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01994109-2026-04-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects
- Acronym: MYSTICOL
- Condition: Sialorrhea
- Intervention (Drug): MYOBLOC
- Intervention (Other): PLACEBO
- Lead sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial (`cardio:pubmed-31930364`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 07d36a1a902dbf1b8069aed1157d25e894eb43326fab4c697d12366eb2d3f1b3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
